New-generation therapy for ANCA-associated vasculitis

被引:4
作者
Jayne, David [1 ]
机构
[1] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England
关键词
Vasculitis; ANCA; Therapy; Clinical trial; Rituximab; RITUXIMAB; CYCLOPHOSPHAMIDE; MAINTENANCE; TRIAL;
D O I
10.1007/s10157-013-0855-z
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Newer therapies for systemic vasculitis are required to improve the efficacy and reduce the toxicity associated with current agents. Our understanding of its pathogenesis is increasing with the availability of targeted therapies. B-cell depletion with rituximab is now a licensed therapy for ANCA vasculitis. Targets for therapy currently in development in ANCA associated vasculitis include blockade of complement and pro-inflammatory cytokines, and inhibition of T cell co-stimulation.
引用
收藏
页码:694 / 696
页数:3
相关论文
共 20 条
[1]   Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects from Anti-Neutrophil Cytoplasmic Autoantibodies-Induced Glomerulonephritis [J].
Bontscho, Julia ;
Schreiber, Adrian ;
Manz, Rudolf A. ;
Schneider, Wolfgang ;
Luft, Friedrich C. ;
Kettritz, Ralph .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (02) :336-348
[2]   Churg-Strauss syndrome with poor-prognosis factors:: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients [J].
Cohen, Pascal ;
Pagnoux, Christian ;
Mahr, Alfred ;
Arene, Jean-Pierre ;
Mouthon, Luc ;
Le Guern, Veronique ;
Andre, Marie-Helene ;
Gayraud, Martine ;
Jayne, David ;
Blockmans, Daniel ;
Cordier, Jean-Franois ;
Guillevin, Loic .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (04) :686-693
[3]   Deoxyspergualin in relapsing and refractory Wegener's granulomatosis [J].
Flossmann, O. ;
Baslund, B. ;
Bruchfeld, A. ;
Tervaert, J. W. Cohen ;
Hall, C. ;
Heinzel, P. ;
Hellmich, B. ;
Luqmani, R. A. ;
Nemoto, K. ;
Tesar, V. ;
Jayne, D. R. W. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) :1125-1130
[4]   Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations [J].
Holle, Julia U. ;
Dubrau, Christin ;
Herlyn, Karen ;
Heller, Martin ;
Ambrosch, Petra ;
Noelle, Bernhard ;
Reinhold-Keller, Eva ;
Gross, Wolfgang L. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) :327-333
[5]   A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies [J].
Jayne, D ;
Rasmussen, N ;
Andrassy, K ;
Bacon, P ;
Tervaert, JWC ;
Dadoniene, J ;
Ekstrand, A ;
Gaskin, G ;
Gregorini, G ;
de Groot, K ;
Gross, W ;
Hagen, EC ;
Mirapeix, E ;
Pettersson, E ;
Siegert, C ;
Sinico, A ;
Tesar, V ;
Westman, K ;
Pusey, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) :36-44
[6]   Update on the European Vasculitis Study Group trials [J].
Jayne, D .
CURRENT OPINION IN RHEUMATOLOGY, 2001, 13 (01) :48-55
[7]   Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis. [J].
Jones, Rachel B. ;
Tervaert, Jan Willem Cohen ;
Hauser, Thomas ;
Luqmani, Raashid ;
Morgan, Matthew D. ;
Peh, Chen Au ;
Savage, Caroline O. ;
Segelmark, Marten ;
Tesar, Vladimir ;
van Paassen, Pieter ;
Walsh, Dorothy ;
Walsh, Michael ;
Westman, Kerstin ;
Jayne, David R. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) :211-220
[8]   A Multicenter Survey of Rituximab Therapy for Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis [J].
Jones, Rachel B. ;
Ferraro, Alastair J. ;
Chaudhry, Afzal N. ;
Brogan, Paul ;
Salama, Alan D. ;
Smith, Kenneth G. C. ;
Savage, Caroline O. S. ;
Jayne, David R. W. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (07) :2156-2168
[9]   Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients [J].
Kim, Min Jeong ;
McDaid, John P. ;
McAdoo, Stephen P. ;
Barratt, Jonathan ;
Molyneux, Karen ;
Masuda, Esteban S. ;
Pusey, Charles D. ;
Tam, Frederick W. K. .
JOURNAL OF IMMUNOLOGY, 2012, 189 (07) :3751-3758
[10]   Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome [J].
Kim, Sophia ;
Marigowda, Gautham ;
Oren, Eyal ;
Israel, Elliot ;
Wechsler, Michael E. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (06) :1336-1343